Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
Study NCT ID:
NCT05427305
Status:
COMPLETED
Last Update Posted:
2022-06-22
First Post:
2022-06-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer
Sponsor:
BioDlink Biopharm Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-20
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-24
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-09
First Submit QC Date:
None
Study First Post Date:
2022-06-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-16
Last Update Post Date:
2022-06-22
Last Update Post Date Type:
ACTUAL